COMBINATION THERAPY FOR CANCER TREATMENT
The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor.
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French German |
Published |
29.08.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present disclosure relates to methods for treating cancer, or preventing cancer recurrence or progression, comprising administering a patient an anti-CD38 antibody and a proteasome inhibitor. |
---|---|
Bibliography: | Application Number: EP20160752904 |